InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Farrell Michael J., Chief Executive Officer. Officer active across 1 company, notably RESMED INC. In total, 73 disclosures have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €2.8m. History available since 19 August 2021. The latest transaction was filed on 7 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Farrell Michael J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations73 total
4,991 shares@ US$205.68950.0032% mcap1.8% of flowResMed Common StockSEC:0000943819-26-000043:1
4,991 shares@ US$146.340.0023% mcap1.3% of flowResMed Common StockSEC:0000943819-26-000043:0
4,991 shares@ US$146.340.0023% mcap1.6% of flowResMed Common StockSEC:0000943819-26-000038:0
4,991 shares@ US$218.54750.0034% mcap2.3% of flowResMed Common StockSEC:0000943819-26-000038:1
4,991 sharesResMed Common StockSEC:0000943819-26-000035:0
4,991 sharesResMed Common StockSEC:0000943819-26-000035:1
4,991 shares@ US$225.50321.7% of flowResMed Common StockSEC:0000943819-26-000021:1
4,991 shares@ US$146.341.1% of flowResMed Common StockSEC:0000943819-26-000021:0
4,991 shares@ US$146.341.3% of flowResMed Common StockSEC:0000943819-26-000016:0
4,991 shares@ US$146.341.3% of flowResMed Common StockSEC:0000943819-26-000011:0
4,991 shares@ US$146.341.3% of flowResMed Common StockSEC:0000943819-26-000003:0
4,991 shares@ US$146.341.4% of flowResMed Common StockSEC:0000943819-25-000187:0
13,551 shares0ResMed Common StockSEC:0000943819-25-000170:0
2,231.545 shares@ US$250.101.1% of flowResMed Common StockSEC:0000943819-25-000116:0
983 shares@ US$101.640.2% of flowResMed Common StockSEC:0000943819-25-000095:0
8,009 shares@ US$101.641.6% of flowResMed Common StockSEC:0000943819-25-000086:0
8,009 shares@ US$101.641.6% of flowResMed Common StockSEC:0000943819-25-000061:0
12,289 shares0ResMed Common StockSEC:0000943819-25-000039:0
8,009 shares@ US$101.641.6% of flowResMed Common StockSEC:0000943819-25-000038:0
8,009 shares@ US$101.641.7% of flowResMed Common StockSEC:0000943819-25-000027:0
8,009 shares@ US$101.641.8% of flowResMed Common StockSEC:0000943819-25-000019:0
8,009 shares@ US$101.641.3% of flowResMed Common StockSEC:0001127602-25-013796:0
8,009 shares@ US$101.641.3% of flowResMed Common StockSEC:0001127602-25-011839:0
8,009 shares@ US$101.641.4% of flowResMed Common StockSEC:0001127602-25-008958:0
8,009 shares@ US$101.641.4% of flowResMed Common StockSEC:0001127602-25-004041:0
25 of 73 declarations
About Farrell Michael J.
Farrell Michael J. is Directeur Général and Chairman and CEO at RESMED INC (XNAS). He has 71 filings in total, and across the sampled filings from 2016-01-19 to 2026-07-09, the reported sell amount is EUR 1916062, with the dominant transaction nature indicated as Levée d'options.
